Pfizer's Avastin biosimilar wins FDA approval
Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.

from Reuters: Health News https://ift.tt/2RKjkll
from Reuters: Health News https://ift.tt/2RKjkll
Comments
Post a Comment